{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-003643","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2022-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.413331+00:00","generated_at":"2026-06-27T20:05:34.218106+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Agenus President and COO Jennifer Buell resigns to lead subsidiary MiNK Therapeutics","bullets":["Dr. Jennifer Buell resigned as President and COO effective December 31, 2021.","She becomes President and CEO of MiNK Therapeutics, a subsidiary of Agenus.","Buell will also serve on Agenus' Executive Council to advise on pipeline synergy.","No successor as President/COO announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-003643","json":"https://secwatch.observer/filing/0001193125-22-003643.json","markdown":"https://secwatch.observer/filing/0001193125-22-003643.md","text":"https://secwatch.observer/filing/0001193125-22-003643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/0001193125-22-003643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/d646332d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:05:34.218106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ede9ee1fd0","claim":"Jennifer Buell resigned as President and Chief Operating Officer at AGENUS INC.","evidence_excerpt":"Effective December 31, 2021, Dr. Jennifer Buell resigned as Agenus Inc.’s (the “Company”) President and Chief Operating Officer to become the President and Chief Executive Officer of MiNK Therapeutics, Inc. (“MiNK”), a subsidiary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/0001193125-22-003643-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}